Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Mol Carcinog Retrieve available abstracts of 26 articles: HTML format

Single Articles

July 2025
1. LIU Z, Lenz HJ, Yu J, Zhang L, et al
   Differential Response and Resistance to KRAS-Targeted Therapy.
   Mol Carcinog. 2025;64:1135-1148.
   PubMed     Abstract available
   
   
   
2. GONG Z, Yu F, Li C, Zhao B, et al
   Four-gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma.
   Mol Carcinog. 2025;64:1209-1221.
   PubMed     Abstract available
   
   
   June 2025
3. CAO L, Xu H, Zhang A, Gao L, et al
   LINC02562 Promotes Progression of Lung Cancer by Regulating NTHL1 Dependent DNA Damage Repair Mechanisms.
   Mol Carcinog. 2025 Jun 11. doi: 10.1002/mc.23935.
   PubMed     Abstract available
   
   
   May 2025
4. LI X, Wu Y, Xie B, Xu M, et al
   SPP1 Promotes NSCLC Brain Metastasis Via Sequestration of Ubiquitin Ligase RNF114 to Facilitate P85alpha Ubiquitination.
   Mol Carcinog. 2025;64:829-841.
   PubMed     Abstract available
   
   
   March 2025
5. MAO S, Li Q, Yang Y, Liu Z, et al
   Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis-Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non-Small Cell Lung Cancer.
   Mol Carcinog. 2025 Mar 4. doi: 10.1002/mc.23899.
   PubMed     Abstract available
   
   
   January 2025
6. GENG Y, Yin T, Li Y, He K, et al
   Computed Tomography-Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non-Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy.
   Mol Carcinog. 2025 Jan 21. doi: 10.1002/mc.23883.
   PubMed     Abstract available
   
   
   
7. LIANG H, Zhang C, Hu M, Hu F, et al
   ALKBH5-Mediated m(6)A Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway.
   Mol Carcinog. 2025;64:57-71.
   PubMed     Abstract available
   
   
   November 2024
8. ZHANG Y, Wang Y, Weng J, Chen J, et al
   Pyroptosis-related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma.
   Mol Carcinog. 2024;63:2218-2236.
   PubMed     Abstract available
   
   
   
9. QIU R, Deng Y, Lu Y, Liu X, et al
   ITGB3-enriched extracellular vesicles mediate the formation of osteoclastic pre-metastatic niche to promote lung adenocarcinoma bone metastasis.
   Mol Carcinog. 2024;63:2190-2204.
   PubMed     Abstract available
   
   
   July 2024
10. YANG Q, Sun K, Gao T, Gao Y, et al
    SIRT1 silencing promotes EMT and Crizotinib resistance by regulating autophagy through AMPK/mTOR/S6K signaling pathway in EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung cancer cells.
    Mol Carcinog. 2024 Jul 30. doi: 10.1002/mc.23799.
    PubMed     Abstract available
    
    
    
11. LAI Q, Wan Y, Zhang Y, Huang Y, et al
    Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
    Mol Carcinog. 2024;63:1260-1274.
    PubMed     Abstract available
    
    
    June 2024
12. DENG Z, Dou L, Luo Z, Liu R, et al
    AKAP95 regulates ubiquitination and degradation of cyclin Ds/Es, influencing the G1/S transition of lung cancer cells.
    Mol Carcinog. 2024 Jun 24. doi: 10.1002/mc.23781.
    PubMed     Abstract available
    
    
    
13. LIANG X, Xu J, Jiang Y, Yan Y, et al
    Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer.
    Mol Carcinog. 2024 Jun 11. doi: 10.1002/mc.23750.
    PubMed     Abstract available
    
    
    May 2024
14. CHEN C, Tang D, Xu S, Xiang L, et al
    The promotion of non-small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species.
    Mol Carcinog. 2024 May 10. doi: 10.1002/mc.23736.
    PubMed     Abstract available
    
    
    
15. DU X, Cheng C, Yang Y, Fan B, et al
    NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m(5)C-dependent manner.
    Mol Carcinog. 2024;63:962-976.
    PubMed     Abstract available
    
    
    
16. YANG Y, Tian Z, He L, Meng H, et al
    RhoGDIbeta inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
    Mol Carcinog. 2024;63:977-990.
    PubMed     Abstract available
    
    
    February 2024
17. FURUSAWA T, Cavero R, Liu Y, Li H, et al
    Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.
    Mol Carcinog. 2024 Feb 27. doi: 10.1002/mc.23705.
    PubMed     Abstract available
    
    
    
18. LI Q, Li J, Wang J, Wang J, et al
    PLEK2 mediates metastasis and invasion via alpha5-nAChR activation in nicotine-induced lung adenocarcinoma.
    Mol Carcinog. 2024;63:253-265.
    PubMed     Abstract available
    
    
    
19. HU M, Cheng H, Yang Y, Xu L, et al
    Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co-mutated lung cancers and downregulated mutant-p53 levels.
    Mol Carcinog. 2024;63:275-285.
    PubMed     Abstract available
    
    
    January 2024
20. LI J, Li Y, Sun X, Wei L, et al
    Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
    Mol Carcinog. 2024 Jan 30. doi: 10.1002/mc.23686.
    PubMed     Abstract available
    
    
    
21. ZHANG X, Zhao Y, Yiminniyaze R, Zhu N, et al
    CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
    Mol Carcinog. 2024;63:61-74.
    PubMed     Abstract available
    
    
    December 2023
22. HUA T, Zhang C, Fu Y, Qin N, et al
    Integrative analyses of N6-methyladenosine-associated single-nucleotide polymorphisms (m6A-SNPs) identify tumor suppressor gene AK9 in lung cancer.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23669.
    PubMed     Abstract available
    
    
    
23. JIANG T, Li N, Xu H, Sun L, et al
    Identification of ATAD3A as a key regulator in non-small cell lung cancer by promoting STAT3-induced cell proliferation and tumor angiogenesis.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23667.
    PubMed     Abstract available
    
    
    
24. ZHANG C, Sun Q, Zhao J, Jiang N, et al
    JSI-124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
    Mol Carcinog. 2023;62:1888-1901.
    PubMed     Abstract available
    
    
    November 2023
25. CHEN J, Kang G, Lei W, Li J, et al
    DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer.
    Mol Carcinog. 2023 Nov 8. doi: 10.1002/mc.23654.
    PubMed     Abstract available
    
    
    October 2023
26. LONG T, Li J, Yin T, Liu K, et al
    A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
    Mol Carcinog. 2023 Oct 3. doi: 10.1002/mc.23642.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.